Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

US Patent 11426464 · Granted Aug 30, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered primate cystine/cysteine degrading enzymes for therapeutic uses2024
Human Kynureninase enzymes and uses thereof2024
Human Kynureninase enzymes and uses thereof2024
Human-enzyme mediated depletion of homocysteine for treating patients with hyper2024
Human-enzyme mediated depletion of homocysteine for treating patients with hyper2024
Engineered antibody Fc variants for enhanced serum half life2024
Tumor specific antibodies and T-cell receptors and methods of identifying the sa2024
Human kynureninase enzymes and uses thereof2023
Human kynureninase enzymes and uses thereof2023
Nicotine degrading enzyme variants2023
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy2023
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological prepa2023